Latest Breaking News On - புதியது மருந்து விண்ணப்பம் - Page 7 : comparemela.com

2021 CSCO | Henlius will Release Four Oral Presentations of Two Upcoming Commercial Products: Novel anti-PD-1 mAb Serplulimab and Bevacizumab Biosimilar

2021 CSCO | Henlius will Release Four Oral Presentations of Two Upcoming Commercial Products: Novel anti-PD-1 mAb Serplulimab and Bevacizumab Biosimilar
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesZhenggang renShukui qinJia fanJin liLingying wuMeeting of chinese society clinical oncologyCancer hospital chinese academy of medical sciencesTongji universityFudan universityEuropean unionNational medical products administrationChinese people liberation army cancer centerAnnual meetingChinese societyClinical oncology

With Prothena Up Over 500% This Year, Is It Too Late to Get in?

With Prothena Up Over 500% This Year, Is It Too Late to Get in?
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Norvo nordiskHideki garrenAlzheimer association international conferenceDrug administrationBristol myers squibbAssociation international conferenceNew drug applicationBristol myersReturn levelஹைடீகீ கர்ரேன்முதுமறதி சங்கம் சர்வதேச மாநாடுபிரிஸ்டல் மைஸ் ஸ்க்விப்ப்சங்கம் சர்வதேச மாநாடுபுதியது மருந்து விண்ணப்பம்பிரிஸ்டல் மைஸ்திரும்ப நிலை

ARDX INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Ardelyx Inc

ARDX INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Ardelyx Inc
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJames maro jrJames maroUnited states district courtDrug administrationArdelyx incKessler topaz meltzerNorthern districtPlaintiff deadlineClass periodNew drug applicationTopaz meltzerஒன்றுபட்டது மாநிலங்களில்ஜேம்ஸ் மாரோ ஜூனியர்ஜேம்ஸ் மாரோஒன்றுபட்டது மாநிலங்களில் மாவட்டம் நீதிமன்றம்

Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients with Advanced Cholangiocarcinoma at ESMO Congress 2021

/PRNewswire/ Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

Jian zhouUnited statesHong kongRhui zhouInnovent biologicsAdimab incyteIntrahepatic cholangiocarcinomaIncyte pemazyreEli lillyPrnewswire innovent biologics incDrug administrationMd anderson cancer centerFudan university zhongshan hospitalNational medical products administrationEuropean society for medical oncologyIncyte corporation

Arctic Vision Announces Addition of Novel Mydriatic Drug MydCombi™ (ARVN004) to Eyenovia Commercialization Deal

/PRNewswire/ Arctic Vision, a China-based biotech company focused on innovative ophthalmic therapies, announced today that it will expand its exclusive.

Hong kongSouth koreaEyenovia optejetEyenovia incDrug administrationGreater chinaArctic visionNew drug applicationMicrodose array printஹாங் காங்தெற்கு கொரியாஅதிகமானது சீனாஆர்க்டிக் பார்வைபுதியது மருந்து விண்ணப்பம்